A decline in IGF1 serum levels in older adults associated with an augmented age-associated disease risk (diabetes, dementia, vascular diseases, and osteoporosis) further suggests that IGF1 might be a modulator of a common underlying pathway for several age-associated conditions and, potentially, aging itself. The gene discussed is IGF1; the disease is osteoporosis.